A recent study published in the journal Cell Press Blue highlights the critical role of the body's cellular response to rhinovirus, the primary cause of the common cold, in determining the severity of illness. Researchers from Yale School of Medicine, led by senior author Ellen Foxman, found that the immediate antiviral defenses activated by nasal cells when the virus enters play a more significant role in health outcomes than the characteristics of the virus itself.
To investigate this response, the research team developed a lab-grown model of human nasal tissue. This model closely mimics the nasal lining by cultivating nasal stem cells for four weeks, allowing researchers to observe the interaction of various cell types in real-time during rhinovirus infection. Notably, the model includes mucus-producing cells and ciliated cells, which are crucial for clearing debris from the airways.
The study reveals that when rhinovirus is detected, nasal cells release interferons, proteins that help prevent the virus from replicating and spreading. A swift interferon response can limit the infection; however, if this response is delayed or blocked, the virus can proliferate rapidly, leading to increased cellular damage and more severe symptoms.
Additionally, the researchers identified that heightened viral replication triggers an inflammatory response, leading to excessive mucus production and airway inflammation, which can exacerbate breathing difficulties. This finding suggests potential therapeutic targets for alleviating symptoms while ensuring effective antiviral defenses.
While the study provides insights into the nasal immune response, the researchers acknowledge that the model lacks some cell types present during actual infections. Future research will focus on how these additional cells, along with other environmental factors, influence the body’s response to rhinovirus infections.